R

ise and shine, everyone, another busy day is on the way. And given that this is the middle of the week, it may be a challenging one, too. But there is always the bright side to consider — the end of the week is now that much closer. Besides, the alternatives to being busy are not terribly attractive. While you mull that over, here are some items of interest to keep you focused. Hope you have a smashing day and, of course, do keep in touch …

The Novartis (NVS) unit in Korea is embroiled in a sexual harassment scandal, Korea Biomedical Review confides. A male employee recently reported to the company that his female boss sexually harassed him by allegedly making excessive physical contacts and sexual comments to him at a dinner that followed a company event. A committee was formed to discuss punishment, but she voluntarily left the drug maker, citing personal circumstances.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy